:::

詳目顯示

回上一頁
題名:Quetiapine Shows Cross-reactivity in Urine Drug Screening for Ketamine
書刊名:Taiwanese Journal of Psychiatry
作者:李彥鋒梁志頌曾裕庭彭嘉和
作者(外文):Lee, Yen-fengLiang, Chih-sungTseng, Yu-tingPeng, Chia-ho
出版日期:2018
卷期:32:4
頁次:頁323-330+a4
主題關鍵詞:交互作用尿液藥物濫用篩檢愷他命QuetiapineCross-reactivityUrine drug screeningKetamine
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(1) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:1
  • 共同引用共同引用:0
  • 點閱點閱:10
期刊論文
1.Chen, W. Y.、Huang, M. C.、Lin, S. K.(2014)。Gender differences in subjective discontinuation symptoms associated with ketamine use。Substance abuse treatment, prevention, and policy,9,(39)1-(39)7。  new window
2.Schifano, F.、Corkery, J.、Oyefeso, A.(2008)。Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006)。J Clin Psychopharmacol,28,114-116。  new window
3.Huang, S. K.、Wang, P. J.、Tseng, W. F.、Syu, F. K.、Lee, M. C.、Shih, R. L.、Chen, M. S.(2015)。NHI-PharmaCloud in Taiwan--A preliminary evaluation using the RE-AIM framework and lessons learned。International Journal of Medical Informatics,84(10),817-825。  new window
4.Samudra, N.、Patel, N.、Womack, K. B.(2016)。Psychosis in Parkinson disease: a review of etiology, phenomenology, and management。Drugs Aging,33,855-863。  new window
5.Leonard, K. E.(2015)。Perspective: beyond the neural circuits。Nature,522,S56。  new window
6.Johnson-Davis, K. L.、Sadler, A. J.、Genzen, J. R.(2016)。A retrospective analysis of urine drugs of abuse immunoassay true positive rates at a national reference laboratory。J Anal Toxicol,40,97-107。  new window
7.Herring, C.、Muzyk, A. J.、Johnston, C.(2011)。Interferences with urine drug screens。J Pharm Pract,24,102-108。  new window
8.Moeller, K. E.、Lee, K. C.、Kissack, J. C.(2008)。Urine drug screening: Practical guide for clinicians。Mayo Clin Proc,83,66-76。  new window
9.White, P. F.、Way, W. L.、Trevor, A. J.(1982)。Ketamine--its pharmacology and therapeutic uses。Anesthesiology,56,119-136。  new window
10.Quibell, R.、Fallon, M.、Mihalyo, M.(2015)。Ketamine。J Pain Symptom Manage,50,268-278。  new window
11.Kavalali, E. T.、Monteggia, L. M.(2015)。How does ketamine elicit a rapid antidepressant response?。Curr Opin Pharmacol,20,35-39。  new window
12.Ng, S. H.、Tse, M. L.、Ng, H. W.(2010)。Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases。Hong Kong Med J,16,6-11。  new window
13.Lian, Z.、Liu, Z.、Liu, R.(2005)。Epidemiological survey of ketamine in China。Chin J Drug Depend,14,280-283。  new window
14.Saitman, A.、Park, H. D.、Fitzgerald, R. L.(2014)。False-positive interferences of common urine drug screen immunoassays: a review。J Anal Toxicol,38,387-396。  new window
15.Liu, Chun-hao、Wang, Hsin-yao、Shen, Shin-heng、Chiu, Yu-wen(20170900)。False Positive Ketamine Urine Immunoassay Screen Result Induced by Quetiapine: A Case Report。Journal of the Formosan Medical Association,116(9),720-722。  new window
16.Harvey, R. C.、James, A. C.、Shields, G. E.(2016)。A systematic review and network meta-analysis to assess the relative efficacy of antipsychotics for the treatment of positive and negative symptoms in early-onset schizophrenia。CNS Drugs,30,27-39。  new window
17.Pagsberg, A. K.、Tarp, S.、Glintborg, D.(2017)。Acute anti-psychotic treatment of children and adolescents with schizophrenia-spectrum disorders: a systematic review and network meta-analysis。J Am Acad Child Adolesc Psychiatry,56,191-202。  new window
18.Lindstrom, L.、Lindstrom, E.、Nilsson, M.(2017)。Maintenance therapy with second generation anti-psychotics for bipolar disorder--a systematic review and meta-analysis。J Affect Disord,213,138-150。  new window
19.Farlow, M. R.、Shamliyan, T. A.(2017)。Benefits and harms of atypical antipsychotics for agitation in adults with dementia。Eur Neuropsychopharmacol,27,217-231。  new window
20.Fisher, D. S.、Handley, S. A.、Taylor, D.(2012)。Measurement of quetiapine and four quetiapine metabolites in human plasma by lc-ms/ms。Biomed Chromatogr,26,1125-1132。  new window
21.DeVane, C. L.、Nemeroff, C. B.(2001)。Clinical pharmacokinetics of quetiapine: an atypical antipsychotic。Clin Pharmacokinet,40,509-522。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關博士論文
 
無相關書籍
 
無相關著作
 
1. Mental Health Services in Malaysia
2. Detoxication Phobia in a Methadone Reduction Program: A Case Report
3. Acute Liver Injury after Initiating Atomoxetine in a Girl Patient with ADHD, Autism, and Epilepsy: The First Case Report in Taiwan
4. Catatonia Associated with Nitroglycerin Abuse
5. The Need of More Interdisciplinary Collaboration in Understanding Negative Symptoms
6. Correlations between Glucose-insulin Profiles and Serum Brain-derived Neurotrophic Factor Level in Patients with Major Depressive Disorder before and during Antidepressant Treatment
7. Effect of Mindfulness Training (Body Scan) on the Five-item Brief Symptom Rating Scale of Depressive Inpatients of Military Personnel: A Pilot Study
8. Prescription Patterns and Safety Monitoring Practices in Medication for Youths with Attention-deficit/Hyperactivity Disorder
9. Possession State by an Animal
10. Cerebellar Arachnoid Cyst-associated Mental Disorder Presented Like Schizophrenia
11. Risk of Hyponatremia Induced by a Selective Serotonin Reuptake Inhibitor: A Care Report
12. Differences in Electrocardiographic Findings between Oder Adult Patients with Bipolar Disorder and Schizophrenia
13. Th17 and Th2 Shift Immune Response in Patients with Chronic Schizophrenia
14. The Combined Treatment of Foot Bath and Antidepressant Reduces the Depressive Symptoms and Suicidal Ideation
15. Reliability of Right-side versus Left-side Derived Parameters of Bi-pulse Transcranial Magnetic Stimulation: Preliminary Findings
 
QR Code
QRCODE